Researchers say a new drug for breast cancer will give patients vital extra time.
The drug called Kadcyla was trialled in Manchester and is now available to patients for the first time.
Doctors say it can extend women's lives by almost six months for those with the most aggressive form of the disease.
Around thirteen hundred women in England could benefit from the drug, which costs £6,000 a month.
Mel Barham reports
More top news
Alfie Jones is cheered on by school pals as he gets out of his wheelchair to compete in the race
Plenty of rain, not much sunshine! Kerrie has the latest...
Consultation launched to reduce the number of front counters at police stations across Lancashire